Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1686179rdf:typepubmed:Citationlld:pubmed
pubmed-article:1686179lifeskim:mentionsumls-concept:C0001175lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C0243009lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C1413246lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C1826471lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C1837441lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C1527148lld:lifeskim
pubmed-article:1686179lifeskim:mentionsumls-concept:C0449435lld:lifeskim
pubmed-article:1686179pubmed:issue10lld:pubmed
pubmed-article:1686179pubmed:dateCreated1992-3-25lld:pubmed
pubmed-article:1686179pubmed:abstractTextA cohort of 111 HIV-infected haemophiliacs has been followed for up to 11 years, during which time 33 patients have been diagnosed with AIDS. Twenty-seven of the cohort developed detectable p24 antigenaemia while remaining free of AIDS. These patients experienced an increased risk of progression to AIDS compared with those patients who were persistently p24-negative (relative risk 7.24; P less than 0.0001, Cox proportional hazards model). The relative risk was reduced to 5.42 (P less than 0.0001) after adjustment for age and cytomegalovirus seropositivity. After adjustment for the patients' declining CD4 lymphocyte count during follow-up, the relative risk fell dramatically to 1.97 and became non-significant (P = 0.2). p24-antigenaemic patients tended to develop AIDS at levels of similar CD4 lymphocyte counts to those who were persistently p24-antigen-negative (median CD4 lymphocyte counts, 70 and 50 x 10(6)/l, respectively). These results suggests that the association between p24 antigenaemia and the rate of progression to AIDS can be explained largely by a more rapid decline in CD4 lymphocyte count among patients with p24 antigenaemia than in those without. The major pathological effects of increased plasma viral load, as detected by the presence or absence of p24 antigenaemia, appear to act via progressive CD4 lymphocyte depletion.lld:pubmed
pubmed-article:1686179pubmed:languageenglld:pubmed
pubmed-article:1686179pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1686179pubmed:citationSubsetIMlld:pubmed
pubmed-article:1686179pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1686179pubmed:statusMEDLINElld:pubmed
pubmed-article:1686179pubmed:monthOctlld:pubmed
pubmed-article:1686179pubmed:issn0269-9370lld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:JanossyGGlld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:WebsterAAlld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:LeeC ACAlld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:KernoffP BPBlld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:GriffithsP...lld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:PhillipsA NANlld:pubmed
pubmed-article:1686179pubmed:authorpubmed-author:ElfordJJlld:pubmed
pubmed-article:1686179pubmed:issnTypePrintlld:pubmed
pubmed-article:1686179pubmed:volume5lld:pubmed
pubmed-article:1686179pubmed:ownerNLMlld:pubmed
pubmed-article:1686179pubmed:authorsCompleteYlld:pubmed
pubmed-article:1686179pubmed:pagination1217-22lld:pubmed
pubmed-article:1686179pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:meshHeadingpubmed-meshheading:1686179-...lld:pubmed
pubmed-article:1686179pubmed:year1991lld:pubmed
pubmed-article:1686179pubmed:articleTitlep24 antigenaemia, CD4 lymphocyte counts and the development of AIDS.lld:pubmed
pubmed-article:1686179pubmed:affiliationDepartment of Public Health, Royal Free Hospital, London, UK.lld:pubmed
pubmed-article:1686179pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1686179pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:1686179lld:pubmed